SCHEMBL11150764

SCHEMBL11150764

CCN1C(=O)CSC1=NC(=O)Nc1c(C)cccc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.55
▸ LMNA P02545 2/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ MAPK14 Q16539 4/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ BLM P54132 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ LCK P06239 3/20 0.39
▸ EGFR P00533 2/20 0.39
▸ MAPK13 O15264 1/20 0.39
▸ FYN P06241 1/20 0.39
▸ HCK P08631 1/20 0.39
▸ SRC P12931 1/20 0.39
▸ JAK3 P52333 1/20 0.39
▸ MAPK12 P53778 1/20 0.39
▸ MAPK11 Q15759 1/20 0.39
▸ PDK1 Q15118 1/20 0.38
▸ PDK2 Q15119 1/20 0.38
▸ PDK3 Q15120 1/20 0.38
▸ PDK4 Q16654 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11143127 0.93 L3MBTL1 (0.59) L3MBTL1LMNAKMT2ASMN1; SMN2EGFR
SCHEMBL11151463 0.92 L3MBTL1 (0.48) L3MBTL1LMNAKMT2ASMN1; SMN2BLM
SCHEMBL11148694 0.88 L3MBTL1 (0.54) L3MBTL1LMNAKMT2ASMN1; SMN2EGFR
SCHEMBL11141810 0.88 L3MBTL1 (0.45) L3MBTL1KMT2ASMN1; SMN2ALDH1A1RAB9A
SCHEMBL11148675 0.86 L3MBTL1 (0.52) L3MBTL1LMNAKMT2ASMN1; SMN2EGFR
SCHEMBL11141779 0.85 GRM5 (0.42) L3MBTL1KMT2AMAPK14SMN1; SMN2GAA
SCHEMBL11144521 0.85 GRM5 (0.42) L3MBTL1KMT2AMAPK14SMN1; SMN2GAA
SCHEMBL11151136 0.85 L3MBTL1 (0.42) L3MBTL1LMNAKMT2ASMN1; SMN2BLM
SCHEMBL11148476 0.84 L3MBTL1 (0.42) L3MBTL1LMNAKMT2ASMN1; SMN2BLM
SCHEMBL11146807 0.82 L3MBTL1 (0.47) L3MBTL1LMNAKMT2ASMN1; SMN2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4402964-A N-Aryl-N'-(3-methyl or ethyl-4-oxothiazolidinylidene)ureas useful for the treatment of epilepsy MCNEILAB, INC. (US) 1983-09-06 — — US disclosed
Send feedback